1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal)

Technology appraisal [TA436] Published: 22 March 2017

  • Guidance
  • Tools and resources
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance